Cargando…
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
Autores principales: | Schlenk, R F, Frech, P, Weber, D, Brossart, P, Horst, H-A, Kraemer, D, Held, G, Ringhoffer, M, Burchardt, A, Kobbe, G, Götze, K, Nachbaur, D, Fischer, T, Lübbert, M, Salih, H R, Salwender, H, Wulf, G, Koller, E, Wattad, M, Fiedler, W, Kremers, S, Kirchen, H, Hertenstein, B, Paschka, P, Gaidzik, V I, Teleanu, V, Heuser, M, Thol, F, Döhner, K, Krauter, J, Ganser, A, Döhner, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420792/ https://www.ncbi.nlm.nih.gov/pubmed/28096533 http://dx.doi.org/10.1038/leu.2017.22 |
Ejemplares similares
-
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
por: Jaramillo, S, et al.
Publicado: (2017) -
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
por: Nagel, Gabriele, et al.
Publicado: (2017) -
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine
por: Schlenk, R. F., et al.
Publicado: (2019) -
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study
por: Schlenk, Richard F., et al.
Publicado: (2016) -
Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)
por: Agrawal, Mridul, et al.
Publicado: (2019)